(Q40604516)

22 September 2017

title

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin (English)

1 reference

22 September 2017

0 references

1 reference

Lance C Pagliaro

1

1 reference

22 September 2017

Afsaneh Keyhani

2

1 reference

22 September 2017

Baoshun Liu

3

1 reference

22 September 2017

Paul Perrotte

4

1 reference

22 September 2017

Deborah Wilson

5

1 reference

22 September 2017

Colin P Dinney

6

1 reference

22 September 2017

publication date

1 November 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

456-462

1 reference

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Gene therapy for bladder cancer using adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Biosafety of in vivo adenovirus-p53 intravesical administration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

Gene therapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900032-2

7 January 2021

10.1016/S1078-1439(03)00032-2

Identifiers

DOI

1 reference

22 September 2017

1 reference